These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 38958121)

  • 1. Effects of novel lactoferrin peptides on LPS-induced alveolar bone destruction in a rat model.
    Yamada S; Chea C; Furusho H; Oda K; Shiba F; Tanimoto K; Tate SI; Miyauchi M; Takata T
    Chem Biol Drug Des; 2024 Jul; 104(1):e14574. PubMed ID: 38958121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effects of orally administrated liposomal bovine lactoferrin on the LPS-induced osteoclastogenesis.
    Yamano E; Miyauchi M; Furusyo H; Kawazoe A; Ishikado A; Makino T; Tanne K; Tanaka E; Takata T
    Lab Invest; 2010 Aug; 90(8):1236-46. PubMed ID: 20421871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanisms of the inhibitory effects of bovine lactoferrin on lipopolysaccharide-mediated osteoclastogenesis.
    Inubushi T; Kawazoe A; Miyauchi M; Kudo Y; Ao M; Ishikado A; Makino T; Takata T
    J Biol Chem; 2012 Jul; 287(28):23527-36. PubMed ID: 22593578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lactoferrin inhibits infection-related osteoclastogenesis without interrupting compressive force-related osteoclastogenesis.
    Inubushi T; Kawazoe A; Miyauchi M; Yanagisawa S; Subarnbhesaj A; Chanbora C; Ayuningtyas NF; Ishikado A; Tanaka E; Takata T
    Arch Oral Biol; 2014 Feb; 59(2):226-32. PubMed ID: 24370195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of OPG-deficient mice with WP9QY, a RANKL-binding peptide, recovers alveolar bone loss by suppressing osteoclastogenesis and enhancing osteoblastogenesis.
    Ozaki Y; Koide M; Furuya Y; Ninomiya T; Yasuda H; Nakamura M; Kobayashi Y; Takahashi N; Yoshinari N; Udagawa N
    PLoS One; 2017; 12(9):e0184904. PubMed ID: 28937990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aminothiazoles inhibit osteoclastogenesis and PGE
    Kats A; Gerasimcik N; Näreoja T; Nederberg J; Grenlöv S; Lagnöhed E; Desai S; Andersson G; Yucel-Lindberg T
    J Cell Mol Med; 2019 Feb; 23(2):1152-1163. PubMed ID: 30506812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral administration of prostaglandin E(2)-specific receptor 4 antagonist inhibits lipopolysaccharide-induced osteoclastogenesis in rat periodontal tissue.
    Oka H; Miyauchi M; Furusho H; Nishihara T; Takata T
    J Periodontol; 2012 Apr; 83(4):506-13. PubMed ID: 21910594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanisms underlying the inhibitory effects of bovine lactoferrin on osteosarcoma.
    Chea C; Haing S; Miyauchi M; Shrestha M; Imanaka H; Takata T
    Biochem Biophys Res Commun; 2019 Jan; 508(3):946-952. PubMed ID: 30545626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aminothiazoles inhibit RANKL- and LPS-mediated osteoclastogenesis and PGE2 production in RAW 264.7 cells.
    Kats A; Norgård M; Wondimu Z; Koro C; Concha Quezada H; Andersson G; Yucel-Lindberg T
    J Cell Mol Med; 2016 Jun; 20(6):1128-38. PubMed ID: 26987561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Porphyromonas gingivalis-derived lysine gingipain enhances osteoclast differentiation induced by tumor necrosis factor-α and interleukin-1β but suppresses that by interleukin-17A: importance of proteolytic degradation of osteoprotegerin by lysine gingipain.
    Akiyama T; Miyamoto Y; Yoshimura K; Yamada A; Takami M; Suzawa T; Hoshino M; Imamura T; Akiyama C; Yasuhara R; Mishima K; Maruyama T; Kohda C; Tanaka K; Potempa J; Yasuda H; Baba K; Kamijo R
    J Biol Chem; 2014 May; 289(22):15621-30. PubMed ID: 24755218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of cathelicidin-related antimicrobial peptide in murine osteoclastogenesis.
    Horibe K; Nakamichi Y; Uehara S; Nakamura M; Koide M; Kobayashi Y; Takahashi N; Udagawa N
    Immunology; 2013 Nov; 140(3):344-51. PubMed ID: 23826736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of osteoprotegerin expression by prostaglandin E2 is crucially involved in lipopolysaccharide-induced osteoclast formation.
    Suda K; Udagawa N; Sato N; Takami M; Itoh K; Woo JT; Takahashi N; Nagai K
    J Immunol; 2004 Feb; 172(4):2504-10. PubMed ID: 14764723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostaglandin E(2) is a main mediator in receptor activator of nuclear factor-kappaB ligand-dependent osteoclastogenesis induced by Porphyromonas gingivalis, Treponema denticola, and Treponema socranskii.
    Choi BK; Moon SY; Cha JH; Kim KW; Yoo YJ
    J Periodontol; 2005 May; 76(5):813-20. PubMed ID: 15898943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coptisine inhibits RANKL-induced NF-κB phosphorylation in osteoclast precursors and suppresses function through the regulation of RANKL and OPG gene expression in osteoblastic cells.
    Lee JW; Iwahashi A; Hasegawa S; Yonezawa T; Jeon WB; Cha BY; Nagai K; Woo JT
    J Nat Med; 2012 Jan; 66(1):8-16. PubMed ID: 21656335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipopolysaccharide stimulates expression of osteoprotegerin and receptor activator of NF-kappa B ligand in periodontal ligament fibroblasts through the induction of interleukin-1 beta and tumor necrosis factor-alpha.
    Wada N; Maeda H; Yoshimine Y; Akamine A
    Bone; 2004 Sep; 35(3):629-35. PubMed ID: 15336598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipopolysaccharide from Prevotella nigrescens stimulates osteoclastogenesis in cocultures of bone marrow mononuclear cells and primary osteoblasts.
    Chung YH; Chang EJ; Kim SJ; Kim HH; Kim HM; Lee SB; Ko JS
    J Periodontal Res; 2006 Aug; 41(4):288-96. PubMed ID: 16827722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muramyl dipeptide enhances osteoclast formation induced by lipopolysaccharide, IL-1 alpha, and TNF-alpha through nucleotide-binding oligomerization domain 2-mediated signaling in osteoblasts.
    Yang S; Takahashi N; Yamashita T; Sato N; Takahashi M; Mogi M; Uematsu T; Kobayashi Y; Nakamichi Y; Takeda K; Akira S; Takada H; Udagawa N; Furusawa K
    J Immunol; 2005 Aug; 175(3):1956-64. PubMed ID: 16034140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor necrosis factor-alpha cooperates with receptor activator of nuclear factor kappaB ligand in generation of osteoclasts in stromal cell-depleted rat bone marrow cell culture.
    Komine M; Kukita A; Kukita T; Ogata Y; Hotokebuchi T; Kohashi O
    Bone; 2001 May; 28(5):474-83. PubMed ID: 11344046
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dual modulation of osteoclast differentiation by lipopolysaccharide.
    Zou W; Bar-Shavit Z
    J Bone Miner Res; 2002 Jul; 17(7):1211-8. PubMed ID: 12096834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wogonin inhibits osteoclast formation induced by lipopolysaccharide.
    Jang S; Bak EJ; Kim M; Kim JM; Chung WY; Cha JH; Yoo YJ
    Phytother Res; 2010 Jul; 24(7):964-8. PubMed ID: 19998398
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.